Results 191 to 200 of about 21,297 (284)

Excellent Outcomes With High‐Risk Pediatric Hepatoblastoma: A Detailed Analysis of a Large, Single‐Center Experience

open access: yesPediatric Transplantation, Volume 30, Issue 6, June 2026.
This large single‐center experience demonstrates that liver transplantation is a highly effective curative strategy for high‐risk pediatric hepatoblastoma. Recurrence risk is driven by tumor biology and treatment timing rather than metastatic disease at diagnosis.
Valeria Ripa   +11 more
wiley   +1 more source

ABO Incompatible Deceased Donor Liver Transplants in Infants (Age < 1 Year): A Single‐Center Experience

open access: yesPediatric Transplantation, Volume 30, Issue 6, June 2026.
The liver transplant waitlist mortality for infants (age < 1 year) is currently the highest among all ages. ABO incompatible (ABOi) liver‐transplantation is one of the strategies to increase transplantation rate in infants and can be safely performed in children less than 1 year of age without plasmapheresis, with excellent long‐term outcomes. ABSTRACT
Heli Bhatt   +9 more
wiley   +1 more source

Donor retention and return patterns in Saudi Arabia: Implications for blood safety and supply stability

open access: yesTransfusion Medicine, Volume 36, Issue 3, Page 222-230, June 2026.
Abstract Background Sustaining a safe and sufficient blood supply requires not only recruiting first‐time donors but also retaining them over time. In Saudi Arabia, donor retention remains poorly understood, with limited data on return behavior, demographic influences, and temporal trends.
Wajnat A. Tounsi, Bushra S. Almalki
wiley   +1 more source

Rhesus blood group haplotype determination by nanopore sequencing and adaptive sampling enables the precise determination of complex allele combinations that could not be accurately determined by standard methods

open access: yesTransfusion, Volume 66, Issue 6, Page 1058-1069, June 2026.
Abstract Background Patients with chronic transfusion needs such as those with sickle cell disease face a high risk of developing antibodies against high‐prevalence antigens in the RH blood group system, complicating transfusion therapy and potentially necessitating stem cell transplantation.
Rebekka Waldmann   +9 more
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Transfusion‐related alpha‐gal syndrome: Two new cases expanding the demographic and geographic spectrum, and evidence of a diagnostic gap in allergic transfusion reaction evaluation

open access: yesTransfusion, Volume 66, Issue 6, Page 1167-1179, June 2026.
Abstract Background Transfusion‐related alpha‐gal syndrome (TRAGS) has recently been proposed as a cause of allergic transfusion reactions (ATRs) in which alpha‐gal‐specific IgE in sensitized group O (or potentially group A) recipients reacts with epitopes on group B or AB plasma‐containing components.
Mackenzie Foster   +9 more
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy